David S. Rosenbloom - 27 Feb 2026 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Reporting relationship: EVP and General Counsel
Issuer ticker: BAX
Reported as of: 27 Feb 2026
Net transaction value: -$26,306
SEC form: 4
Accepted by SEC: 03 Mar 2026, 19:07:36 UTC
Prior SEC filing: 11 Feb 2026
Next SEC filing: 10 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Olson, as attorney-in-fact for David S. Rosenbloom

Key filing fact

David S. Rosenbloom filed Form 4 for BAXTER INTERNATIONAL INC (BAX) on 03 Mar 2026.

Key facts

This page summarizes David S. Rosenbloom's Form 4 filing for BAXTER INTERNATIONAL INC (BAX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 19:07.

Change

Previous filing in this sequence was filed on 11 Feb 2026.
Current net transaction value: -$26,306.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001924321 Primary reporting owner

Rosenbloom David S.

Relationship: EVP and General Counsel
Address: ONE BAXTER PARKWAY, DEERFIELD
Signature: /s/ Kimberly Olson, as attorney-in-fact for David S. Rosenbloom
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BAX transaction

Common Stock, $1 par value

Award

Transaction value: $0
Shares: +26,709
Change %: +22%
Price: $0.000000
Shares after: 146,173
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1

BAX transaction

Common Stock, $1 par value

Tax liability

Transaction value: $26,306
Shares: -1,336
Change %: -0.91%
Price: $19.69
Shares after: 144,837
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BAX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +64,655
Change %
Price: $0.000000
Shares after: 64,655
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Common Stock, $1 par value
Underlying amount: 64,655
Exercise price: $20.37
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.

Footnote F2

Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.

Footnote F3

The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.